Global Oral Hypoglycemic Agents (OHAs) Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 14 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.

This report studies the global Oral Hypoglycemic Agents (OHAs) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Hypoglycemic Agents (OHAs), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Hypoglycemic Agents (OHAs) that contribute to its increasing demand across many markets.

The global Oral Hypoglycemic Agents (OHAs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market.

Highlights and key features of the study
Global Oral Hypoglycemic Agents (OHAs) total production and demand, 2018-2029, (K Units)
Global Oral Hypoglycemic Agents (OHAs) total production value, 2018-2029, (USD Million)
Global Oral Hypoglycemic Agents (OHAs) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Hypoglycemic Agents (OHAs) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Oral Hypoglycemic Agents (OHAs) domestic production, consumption, key domestic manufacturers and share
Global Oral Hypoglycemic Agents (OHAs) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Oral Hypoglycemic Agents (OHAs) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Oral Hypoglycemic Agents (OHAs) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Oral Hypoglycemic Agents (OHAs) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Novonordisk, Sanofi-Aventis, Servier, Huadong Medicine and Wanbang Biopharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Hypoglycemic Agents (OHAs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oral Hypoglycemic Agents (OHAs) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oral Hypoglycemic Agents (OHAs) Market, Segmentation by Type
    Sulfonylureas
    Metformin
    Thiazolidinediones
    Alpha-Glucosidase Inhibitors

Global Oral Hypoglycemic Agents (OHAs) Market, Segmentation by Application
    Type 2 Diabetes Mellitus
    Type 1 Diabetes Mellitus

Companies Profiled:
    Pfizer
    GlaxoSmithKline
    Bayer
    Bristol-Myers Squibb
    Novonordisk
    Sanofi-Aventis
    Servier
    Huadong Medicine
    Wanbang Biopharmaceuticals
    Double-Crane Pharmaceutical
    Guangzhou Pharmaceutical

Key Questions Answered
1. How big is the global Oral Hypoglycemic Agents (OHAs) market?
2. What is the demand of the global Oral Hypoglycemic Agents (OHAs) market?
3. What is the year over year growth of the global Oral Hypoglycemic Agents (OHAs) market?
4. What is the production and production value of the global Oral Hypoglycemic Agents (OHAs) market?
5. Who are the key producers in the global Oral Hypoglycemic Agents (OHAs) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Hypoglycemic Agents (OHAs) Introduction
    1.2 World Oral Hypoglycemic Agents (OHAs) Supply & Forecast
        1.2.1 World Oral Hypoglycemic Agents (OHAs) Production Value (2018 & 2022 & 2029)
        1.2.2 World Oral Hypoglycemic Agents (OHAs) Production (2018-2029)
        1.2.3 World Oral Hypoglycemic Agents (OHAs) Pricing Trends (2018-2029)
    1.3 World Oral Hypoglycemic Agents (OHAs) Production by Region (Based on Production Site)
        1.3.1 World Oral Hypoglycemic Agents (OHAs) Production Value by Region (2018-2029)
        1.3.2 World Oral Hypoglycemic Agents (OHAs) Production by Region (2018-2029)
        1.3.3 World Oral Hypoglycemic Agents (OHAs) Average Price by Region (2018-2029)
        1.3.4 North America Oral Hypoglycemic Agents (OHAs) Production (2018-2029)
        1.3.5 Europe Oral Hypoglycemic Agents (OHAs) Production (2018-2029)
        1.3.6 China Oral Hypoglycemic Agents (OHAs) Production (2018-2029)
        1.3.7 Japan Oral Hypoglycemic Agents (OHAs) Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Hypoglycemic Agents (OHAs) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Hypoglycemic Agents (OHAs) Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oral Hypoglycemic Agents (OHAs) Demand (2018-2029)
    2.2 World Oral Hypoglycemic Agents (OHAs) Consumption by Region
        2.2.1 World Oral Hypoglycemic Agents (OHAs) Consumption by Region (2018-2023)
        2.2.2 World Oral Hypoglycemic Agents (OHAs) Consumption Forecast by Region (2024-2029)
    2.3 United States Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)
    2.4 China Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)
    2.5 Europe Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)
    2.6 Japan Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)
    2.7 South Korea Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)
    2.8 ASEAN Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)
    2.9 India Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029)

3 World Oral Hypoglycemic Agents (OHAs) Manufacturers Competitive Analysis
    3.1 World Oral Hypoglycemic Agents (OHAs) Production Value by Manufacturer (2018-2023)
    3.2 World Oral Hypoglycemic Agents (OHAs) Production by Manufacturer (2018-2023)
    3.3 World Oral Hypoglycemic Agents (OHAs) Average Price by Manufacturer (2018-2023)
    3.4 Oral Hypoglycemic Agents (OHAs) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Oral Hypoglycemic Agents (OHAs) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Oral Hypoglycemic Agents (OHAs) in 2022
        3.5.3 Global Concentration Ratios (CR8) for Oral Hypoglycemic Agents (OHAs) in 2022
    3.6 Oral Hypoglycemic Agents (OHAs) Market: Overall Company Footprint Analysis
        3.6.1 Oral Hypoglycemic Agents (OHAs) Market: Region Footprint
        3.6.2 Oral Hypoglycemic Agents (OHAs) Market: Company Product Type Footprint
        3.6.3 Oral Hypoglycemic Agents (OHAs) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Oral Hypoglycemic Agents (OHAs) Production Value Comparison
        4.1.1 United States VS China: Oral Hypoglycemic Agents (OHAs) Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Oral Hypoglycemic Agents (OHAs) Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Oral Hypoglycemic Agents (OHAs) Production Comparison
        4.2.1 United States VS China: Oral Hypoglycemic Agents (OHAs) Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oral Hypoglycemic Agents (OHAs) Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Oral Hypoglycemic Agents (OHAs) Consumption Comparison
        4.3.1 United States VS China: Oral Hypoglycemic Agents (OHAs) Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Oral Hypoglycemic Agents (OHAs) Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Oral Hypoglycemic Agents (OHAs) Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Oral Hypoglycemic Agents (OHAs) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production (2018-2023)
    4.5 China Based Oral Hypoglycemic Agents (OHAs) Manufacturers and Market Share
        4.5.1 China Based Oral Hypoglycemic Agents (OHAs) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value (2018-2023)
        4.5.3 China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production (2018-2023)
    4.6 Rest of World Based Oral Hypoglycemic Agents (OHAs) Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Oral Hypoglycemic Agents (OHAs) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production (2018-2023)

5 Market Analysis by Type
    5.1 World Oral Hypoglycemic Agents (OHAs) Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Sulfonylureas
        5.2.2 Metformin
        5.2.3 Thiazolidinediones
        5.2.4 Alpha-Glucosidase Inhibitors
    5.3 Market Segment by Type
        5.3.1 World Oral Hypoglycemic Agents (OHAs) Production by Type (2018-2029)
        5.3.2 World Oral Hypoglycemic Agents (OHAs) Production Value by Type (2018-2029)
        5.3.3 World Oral Hypoglycemic Agents (OHAs) Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oral Hypoglycemic Agents (OHAs) Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Type 2 Diabetes Mellitus
        6.2.2 Type 1 Diabetes Mellitus
    6.3 Market Segment by Application
        6.3.1 World Oral Hypoglycemic Agents (OHAs) Production by Application (2018-2029)
        6.3.2 World Oral Hypoglycemic Agents (OHAs) Production Value by Application (2018-2029)
        6.3.3 World Oral Hypoglycemic Agents (OHAs) Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Oral Hypoglycemic Agents (OHAs) Product and Services
        7.1.4 Pfizer Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Details
        7.2.2 GlaxoSmithKline Major Business
        7.2.3 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product and Services
        7.2.4 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 GlaxoSmithKline Recent Developments/Updates
        7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.3 Bayer
        7.3.1 Bayer Details
        7.3.2 Bayer Major Business
        7.3.3 Bayer Oral Hypoglycemic Agents (OHAs) Product and Services
        7.3.4 Bayer Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Bayer Recent Developments/Updates
        7.3.6 Bayer Competitive Strengths & Weaknesses
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Details
        7.4.2 Bristol-Myers Squibb Major Business
        7.4.3 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product and Services
        7.4.4 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Bristol-Myers Squibb Recent Developments/Updates
        7.4.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.5 Novonordisk
        7.5.1 Novonordisk Details
        7.5.2 Novonordisk Major Business
        7.5.3 Novonordisk Oral Hypoglycemic Agents (OHAs) Product and Services
        7.5.4 Novonordisk Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Novonordisk Recent Developments/Updates
        7.5.6 Novonordisk Competitive Strengths & Weaknesses
    7.6 Sanofi-Aventis
        7.6.1 Sanofi-Aventis Details
        7.6.2 Sanofi-Aventis Major Business
        7.6.3 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product and Services
        7.6.4 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Sanofi-Aventis Recent Developments/Updates
        7.6.6 Sanofi-Aventis Competitive Strengths & Weaknesses
    7.7 Servier
        7.7.1 Servier Details
        7.7.2 Servier Major Business
        7.7.3 Servier Oral Hypoglycemic Agents (OHAs) Product and Services
        7.7.4 Servier Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Servier Recent Developments/Updates
        7.7.6 Servier Competitive Strengths & Weaknesses
    7.8 Huadong Medicine
        7.8.1 Huadong Medicine Details
        7.8.2 Huadong Medicine Major Business
        7.8.3 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product and Services
        7.8.4 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Huadong Medicine Recent Developments/Updates
        7.8.6 Huadong Medicine Competitive Strengths & Weaknesses
    7.9 Wanbang Biopharmaceuticals
        7.9.1 Wanbang Biopharmaceuticals Details
        7.9.2 Wanbang Biopharmaceuticals Major Business
        7.9.3 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product and Services
        7.9.4 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
        7.9.6 Wanbang Biopharmaceuticals Competitive Strengths & Weaknesses
    7.10 Double-Crane Pharmaceutical
        7.10.1 Double-Crane Pharmaceutical Details
        7.10.2 Double-Crane Pharmaceutical Major Business
        7.10.3 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
        7.10.4 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Double-Crane Pharmaceutical Recent Developments/Updates
        7.10.6 Double-Crane Pharmaceutical Competitive Strengths & Weaknesses
    7.11 Guangzhou Pharmaceutical
        7.11.1 Guangzhou Pharmaceutical Details
        7.11.2 Guangzhou Pharmaceutical Major Business
        7.11.3 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
        7.11.4 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Guangzhou Pharmaceutical Recent Developments/Updates
        7.11.6 Guangzhou Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Hypoglycemic Agents (OHAs) Industry Chain
    8.2 Oral Hypoglycemic Agents (OHAs) Upstream Analysis
        8.2.1 Oral Hypoglycemic Agents (OHAs) Core Raw Materials
        8.2.2 Main Manufacturers of Oral Hypoglycemic Agents (OHAs) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Oral Hypoglycemic Agents (OHAs) Production Mode
    8.6 Oral Hypoglycemic Agents (OHAs) Procurement Model
    8.7 Oral Hypoglycemic Agents (OHAs) Industry Sales Model and Sales Channels
        8.7.1 Oral Hypoglycemic Agents (OHAs) Sales Model
        8.7.2 Oral Hypoglycemic Agents (OHAs) Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oral Hypoglycemic Agents (OHAs) Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Oral Hypoglycemic Agents (OHAs) Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Oral Hypoglycemic Agents (OHAs) Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Region (2018-2023)
    Table 5. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Region (2024-2029)
    Table 6. World Oral Hypoglycemic Agents (OHAs) Production by Region (2018-2023) & (K Units)
    Table 7. World Oral Hypoglycemic Agents (OHAs) Production by Region (2024-2029) & (K Units)
    Table 8. World Oral Hypoglycemic Agents (OHAs) Production Market Share by Region (2018-2023)
    Table 9. World Oral Hypoglycemic Agents (OHAs) Production Market Share by Region (2024-2029)
    Table 10. World Oral Hypoglycemic Agents (OHAs) Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Oral Hypoglycemic Agents (OHAs) Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Oral Hypoglycemic Agents (OHAs) Major Market Trends
    Table 13. World Oral Hypoglycemic Agents (OHAs) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Oral Hypoglycemic Agents (OHAs) Consumption by Region (2018-2023) & (K Units)
    Table 15. World Oral Hypoglycemic Agents (OHAs) Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Oral Hypoglycemic Agents (OHAs) Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Oral Hypoglycemic Agents (OHAs) Producers in 2022
    Table 18. World Oral Hypoglycemic Agents (OHAs) Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Oral Hypoglycemic Agents (OHAs) Producers in 2022
    Table 20. World Oral Hypoglycemic Agents (OHAs) Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Oral Hypoglycemic Agents (OHAs) Company Evaluation Quadrant
    Table 22. World Oral Hypoglycemic Agents (OHAs) Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Oral Hypoglycemic Agents (OHAs) Production Site of Key Manufacturer
    Table 24. Oral Hypoglycemic Agents (OHAs) Market: Company Product Type Footprint
    Table 25. Oral Hypoglycemic Agents (OHAs) Market: Company Product Application Footprint
    Table 26. Oral Hypoglycemic Agents (OHAs) Competitive Factors
    Table 27. Oral Hypoglycemic Agents (OHAs) New Entrant and Capacity Expansion Plans
    Table 28. Oral Hypoglycemic Agents (OHAs) Mergers & Acquisitions Activity
    Table 29. United States VS China Oral Hypoglycemic Agents (OHAs) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Oral Hypoglycemic Agents (OHAs) Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Oral Hypoglycemic Agents (OHAs) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Oral Hypoglycemic Agents (OHAs) Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Market Share (2018-2023)
    Table 37. China Based Oral Hypoglycemic Agents (OHAs) Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Market Share (2018-2023)
    Table 42. Rest of World Based Oral Hypoglycemic Agents (OHAs) Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Market Share (2018-2023)
    Table 47. World Oral Hypoglycemic Agents (OHAs) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Oral Hypoglycemic Agents (OHAs) Production by Type (2018-2023) & (K Units)
    Table 49. World Oral Hypoglycemic Agents (OHAs) Production by Type (2024-2029) & (K Units)
    Table 50. World Oral Hypoglycemic Agents (OHAs) Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Oral Hypoglycemic Agents (OHAs) Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Oral Hypoglycemic Agents (OHAs) Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Oral Hypoglycemic Agents (OHAs) Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Oral Hypoglycemic Agents (OHAs) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Oral Hypoglycemic Agents (OHAs) Production by Application (2018-2023) & (K Units)
    Table 56. World Oral Hypoglycemic Agents (OHAs) Production by Application (2024-2029) & (K Units)
    Table 57. World Oral Hypoglycemic Agents (OHAs) Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Oral Hypoglycemic Agents (OHAs) Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Oral Hypoglycemic Agents (OHAs) Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Oral Hypoglycemic Agents (OHAs) Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 62. Pfizer Major Business
    Table 63. Pfizer Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 64. Pfizer Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Pfizer Recent Developments/Updates
    Table 66. Pfizer Competitive Strengths & Weaknesses
    Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 68. GlaxoSmithKline Major Business
    Table 69. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 70. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. GlaxoSmithKline Recent Developments/Updates
    Table 72. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 73. Bayer Basic Information, Manufacturing Base and Competitors
    Table 74. Bayer Major Business
    Table 75. Bayer Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 76. Bayer Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Bayer Recent Developments/Updates
    Table 78. Bayer Competitive Strengths & Weaknesses
    Table 79. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 80. Bristol-Myers Squibb Major Business
    Table 81. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 82. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Bristol-Myers Squibb Recent Developments/Updates
    Table 84. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 85. Novonordisk Basic Information, Manufacturing Base and Competitors
    Table 86. Novonordisk Major Business
    Table 87. Novonordisk Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 88. Novonordisk Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Novonordisk Recent Developments/Updates
    Table 90. Novonordisk Competitive Strengths & Weaknesses
    Table 91. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
    Table 92. Sanofi-Aventis Major Business
    Table 93. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 94. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Sanofi-Aventis Recent Developments/Updates
    Table 96. Sanofi-Aventis Competitive Strengths & Weaknesses
    Table 97. Servier Basic Information, Manufacturing Base and Competitors
    Table 98. Servier Major Business
    Table 99. Servier Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 100. Servier Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Servier Recent Developments/Updates
    Table 102. Servier Competitive Strengths & Weaknesses
    Table 103. Huadong Medicine Basic Information, Manufacturing Base and Competitors
    Table 104. Huadong Medicine Major Business
    Table 105. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 106. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Huadong Medicine Recent Developments/Updates
    Table 108. Huadong Medicine Competitive Strengths & Weaknesses
    Table 109. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 110. Wanbang Biopharmaceuticals Major Business
    Table 111. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 112. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Wanbang Biopharmaceuticals Recent Developments/Updates
    Table 114. Wanbang Biopharmaceuticals Competitive Strengths & Weaknesses
    Table 115. Double-Crane Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 116. Double-Crane Pharmaceutical Major Business
    Table 117. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 118. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Double-Crane Pharmaceutical Recent Developments/Updates
    Table 120. Guangzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 121. Guangzhou Pharmaceutical Major Business
    Table 122. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 123. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Oral Hypoglycemic Agents (OHAs) Upstream (Raw Materials)
    Table 125. Oral Hypoglycemic Agents (OHAs) Typical Customers
    Table 126. Oral Hypoglycemic Agents (OHAs) Typical Distributors
List of Figure
    Figure 1. Oral Hypoglycemic Agents (OHAs) Picture
    Figure 2. World Oral Hypoglycemic Agents (OHAs) Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oral Hypoglycemic Agents (OHAs) Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Oral Hypoglycemic Agents (OHAs) Production (2018-2029) & (K Units)
    Figure 5. World Oral Hypoglycemic Agents (OHAs) Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Region (2018-2029)
    Figure 7. World Oral Hypoglycemic Agents (OHAs) Production Market Share by Region (2018-2029)
    Figure 8. North America Oral Hypoglycemic Agents (OHAs) Production (2018-2029) & (K Units)
    Figure 9. Europe Oral Hypoglycemic Agents (OHAs) Production (2018-2029) & (K Units)
    Figure 10. China Oral Hypoglycemic Agents (OHAs) Production (2018-2029) & (K Units)
    Figure 11. Japan Oral Hypoglycemic Agents (OHAs) Production (2018-2029) & (K Units)
    Figure 12. Oral Hypoglycemic Agents (OHAs) Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 15. World Oral Hypoglycemic Agents (OHAs) Consumption Market Share by Region (2018-2029)
    Figure 16. United States Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 17. China Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 18. Europe Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 19. Japan Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 22. India Oral Hypoglycemic Agents (OHAs) Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Oral Hypoglycemic Agents (OHAs) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Hypoglycemic Agents (OHAs) Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Hypoglycemic Agents (OHAs) Markets in 2022
    Figure 26. United States VS China: Oral Hypoglycemic Agents (OHAs) Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Oral Hypoglycemic Agents (OHAs) Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oral Hypoglycemic Agents (OHAs) Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Market Share 2022
    Figure 30. China Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Oral Hypoglycemic Agents (OHAs) Production Market Share 2022
    Figure 32. World Oral Hypoglycemic Agents (OHAs) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Type in 2022
    Figure 34. Sulfonylureas
    Figure 35. Metformin
    Figure 36. Thiazolidinediones
    Figure 37. Alpha-Glucosidase Inhibitors
    Figure 38. World Oral Hypoglycemic Agents (OHAs) Production Market Share by Type (2018-2029)
    Figure 39. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Type (2018-2029)
    Figure 40. World Oral Hypoglycemic Agents (OHAs) Average Price by Type (2018-2029) & (USD/Unit)
    Figure 41. World Oral Hypoglycemic Agents (OHAs) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Application in 2022
    Figure 43. Type 2 Diabetes Mellitus
    Figure 44. Type 1 Diabetes Mellitus
    Figure 45. World Oral Hypoglycemic Agents (OHAs) Production Market Share by Application (2018-2029)
    Figure 46. World Oral Hypoglycemic Agents (OHAs) Production Value Market Share by Application (2018-2029)
    Figure 47. World Oral Hypoglycemic Agents (OHAs) Average Price by Application (2018-2029) & (USD/Unit)
    Figure 48. Oral Hypoglycemic Agents (OHAs) Industry Chain
    Figure 49. Oral Hypoglycemic Agents (OHAs) Procurement Model
    Figure 50. Oral Hypoglycemic Agents (OHAs) Sales Model
    Figure 51. Oral Hypoglycemic Agents (OHAs) Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Oral Hypoglycemic Agents (OHAs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Oral Hypoglycemic Agents (OHAs) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Pharma & Healthcare

Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.

Global Oral Hypoglycemic Agents (OHAs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Hypoglycemic Agents (OHAs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Hypoglycemic Agents (OHAs) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

oral hypoglycemic agents ohas

Oral Hypoglycemic Agents (OHAs)

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>